Two Sigma Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,500
| Closed | -$454K | – | 2728 |
|
|
2023
Q1 | $454K | Sell |
2,500
-88,900
| -97% | -$16.1M | ﹤0.01% | 1978 |
|
|
2022
Q4 | $18M | Buy |
91,400
+16,700
| +22% | +$3.28M | 0.05% | 371 |
|
|
2022
Q3 | $16.8M | Buy |
+74,700
| New | +$16.8M | 0.05% | 364 |
|
|
2022
Q2 | – | Sell |
-2,300
| Closed | -$292K | – | 2942 |
|
|
2022
Q1 | $292K | Buy |
2,300
+400
| +21% | +$50.8K | ﹤0.01% | 2230 |
|
|
2021
Q4 | $249K | Sell |
1,900
-800
| -30% | -$105K | ﹤0.01% | 2206 |
|
|
2021
Q3 | $330K | Buy |
2,700
+100
| +4% | +$12.2K | ﹤0.01% | 2079 |
|
|
2021
Q2 | $296K | Sell |
2,600
-700
| -21% | -$79.7K | ﹤0.01% | 2146 |
|
|
2021
Q1 | $397K | Sell |
3,300
-2,500
| -43% | -$301K | ﹤0.01% | 2110 |
|
|
2020
Q4 | $589K | Buy |
+5,800
| New | +$589K | ﹤0.01% | 1808 |
|
|
2020
Q1 | – | Sell |
-3,500
| Closed | -$264K | – | 2600 |
|
|
2019
Q4 | $264K | Buy |
+3,500
| New | +$264K | ﹤0.01% | 2103 |
|